2017 - maintenantSpécialiste en pharmacovigilance (PSUR/PBRER, RMP, Signal detection) actuelleemnt Local safety officer (ICSR, literature review, legislation review, PV agreement, contact for HAs) en poste à Zurich (Suisse).
Langues: français anglais allemand
IT: Office Argus
2013 - 2017Senior Safety Scientist at Archimed a member of the Fishawack group of companies.
Located in Switzerland (Aarau / german speaking part).
The new EU pharmacovigilance legislation represents the biggest change ever in pharmacovigilance (PV) activities in the pharmaceutical industry. The risk of drug withdrawal is increasing for those products on the market that don’t meet the requirements for high-quality reporting of safety data. The ultimate goal is to ensure the best possible medical treatment for patients. This is achieved through continuous monitoring and evaluation of the benefits and risks of marketed drugs. In addition, transparent communication to healthcare professionals and their patients is a key requirement from health authorities.
Since 1997, Fishawack Archimed has supported pharmaceutical, biotechnology and medical device companies with pharmacovigilance and regulatory support services.
CEREP
- Responsable scientifique
SAINT-QUENTIN 2001 - 2011Licencié pour raison économique : no comment !
